References
1.S.C. Prasad, S. Kotigadde, M. Shekhar, et al.Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification.Int J Microbiol, 2014 (2014), pp. 1-9
2.F. Khan, R. Muhammad, M.R. Khan, et al. Efficacy of topical clotrimazole in treatment of otomycosis.J Ayub Med Coll Abbottabad, 25 (2013), pp. 78-80
3.H. Nowrozi, F.D. Arabi, H.G. Mehraban, et al.Mycological and clinical study of otomycosis in Tehran, Iran.Bull Environ Pharmacol Life Sci, 3 (2014), pp. 29-31
4.Moharram AM, Ahmed HE, Nasr SAM: Otomycosis in Assiut, Egypt. J Basic Appl Mycol 4, 1–11 (2013)
5.Anwar K, Gohar MS: Otomycosis; clinical features, predisposing factors and treatment implications. Pak J Med Sci 30, 564–567 (2014)
6.De la Paz Cota BR, Cepero Vega PP. Efficacy and safety of eberconazole 1% otic solution compared to clotrimazole 1% solution in patients with otomycosis.Am J Otolaryngol. 2018 May - Jun;39(3):307-312.
7.B. Barati, S. Okhovvat, A. Goljanian, et al.Otomycosis in central Iran: a clinical and mycological study.Iran Red Crescent Med J, 13 (2011), pp. 873-876
8.T. Ho, J. Vraben, D. Yoo, N. Coker. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg, 135 (2006), pp. 787-791
9.Peng YX, Diagnosis and Treatment of Otitis Externa Mycotica: Experiences with 216 Cases.Chinese Journal of Otology Vo1.17,No.4 , 2019
10. Jia X, Liang Q, Chi F, et al. Otomycosis in Shanghai: Aetiology, clinical features and therapy. Mycoses 55, 404–409 (2012)
11.Abdelazeem M, Gamea A, Mubarak H, et al. Epidemiology, causative agents, and risk factors affecting human otomycosis infections. Turk J Med Sci 45, 820–826 (2015)
12. Mohammed Rifaat Ahmed, Ashraf Saad Abou-Halawa, Waheed F. Hessam,et al.A search for new otomycotic species and their sensitivity to different antifungals.Interv Med Appl Sci. 2018 Sep; 10(3): 145–149.
13.Agarwal P, Devi L S. Otomycosis in a Rural Community Attending a Tertiary Care Hospital: Assessment of Risk Factors and Identification of Fungal and Bacterial Agents. J Clin Diagn Res. 2017;11(06):DC14–DC18.
14.A.A. Malik, S.N. Malik, M.A. Aslam, et al. Comparative efficacy of topical clotrimazole and 3% salicylic acid in otomycosis.Rawal Med J, 13 (2012), pp. 46-49
15. Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria.Mycoses. 2008;51(1):67-70.
16.C. Linstrom, F. Lucente.Diseasesof the external ear.J. Bailey, T. Johnson, D. Newlands (Eds.), Head& neck surgery-otolaryngology, Lippincott Williams & Wilkins, Philadelphia,PA (2014), pp. 1987-2002
17.Satish H S, Viswanatha B, Manjuladevi M. A Clinical Study of Otomycosis. IOSR J Dental Med Sci. 2013;5(02):57–62.
18.Li Y, He L. Diagnosis and treatment of otomycosis in southern China.Mycoses. 2019 Nov;62(11):1064-1068.
19. Ren Y, Zhang Q, Yu Z, et al. Clinical analysis of external ear canal coating by otoendoscopy on otomycosis external with triamcinolone acetonide and econazole nitrate cream. Lin Chung Er Bi Yan HouTou Jing Wai Ke Za Zhi. 2015;29:1304‐1305.